Intravitreal and posterior subtenon triamcinolone acetonide for severe acute posterior multifocal placoid pigment epitheliopathy.

Abstract

A 21-year-old man presented with visual acuity of 20/200 in both eyes. The fundus picture, fluorescein angiography, and optical coherence tomography revealed severe bilateral acute posterior multifocal placoid pigment epitheliopathy and serous macular detachments. We treated the patient with triamcinolone acetonide, an intravitreal injection (4 mg/0.1 mL) in one eye and a posterior subtenon injection (40 mg/1 mL) in the other eye. Within 2 weeks the visual acuity was 20/80 in both eyes. At the 8-week follow-up visit his vision was 20/63 bilaterally. One year later the vision remained 20/63 in both eyes. In this patient, the triamcinolone acetonide injections, whether administered intravitreally or via the posterior subtenon route, achieved similar anatomic and functional recovery results.

• Authors: Raul N G Vianna, Vinícius Vanzan, Remo Turchetti, Miguel N Burnier Jr
• Journal: Arquivos brasileiros de oftalmologia (Arq Bras Oftalmol) 2019 May-Jun Vol. 82 Issue 3 Pg. 233-235 ISSN: 1678-2925 [Electronic] Brazil
• PMID: 30916213 (Publication Type: Case Reports, Letter)

Chemical References

• Anti-Inflammatory Agents
• Triamcinolone Acetonide

Topics

• Anti-Inflammatory Agents (administration & dosage)
• Fluorescein Angiography
• Humans
• Intravitreal Injections (methods)
• Male
• Tenon Capsule
• Time Factors
• Tomography, Optical Coherence (methods)
• Treatment Outcome
• Triamcinolone Acetonide (administration & dosage)
• Visual Acuity
• White Dot Syndromes (diagnostic imaging, drug therapy, pathology)
• Young Adult